Modi govt appoints Arnab Goswami, Ram Bahadur, 2 other saffronists as members of NMML

Agencies
November 3, 2018

New Delhi, Nov 3: The Centre has appointed journalist Arnab Goswami, former Foreign Secretary S Jaishankar, BJP MP Vinay Sahasrabuddhe and IGNCA chairman Ram Bahadur Rai as members of Nehru Memorial Museum and Library Society, replacing four members who had opposed the move to build a museum for all prime ministers at the Teen Murti Estate.

Former Union Minister MJ Akbar, who resigned from the Cabinet on October 17 in the wake of allegations of sexual harassment levelled by several women journalists, however, continues to be the vice chairman of the NMML executive council.

According to a notification on October 29, the culture ministry replaced economist Nitin Desai, professor Udayan Mishra and former bureaucrat BP Singh. Another member Pratap Bhanu Mehta had resigned in 2016 over the appointment of Shakti Sinha as NMML director.

The newly appointed members will serve until April 25, 2020, the order said.

Pratap Bhanu Mehta, BP Singh and Udayan Mishra, who have been replaced, had openly spoken against the decision to set up the museum for PMs at the complex, sources said.

"Their tenures have not ended. They have been replaced," NMML director Shakti Sinha told PTI on the development.

Asked about the reason behind the appointments, Sinha said they will help meet the goal to develop NMML into a centre of research as envisioned by the present government

"This is part of a bigger plan to make NMML a centre of research. Ram Bahadur Rai has been commenting on the Indian political scene for the last 50 years. He personally knew some of the PMs," Sinha said

"Jaishankar will bring us an insight into how decisions are made at the top and Goswami, as a senior journalist and a scholar in his earlier days, will also contribute immensely to our plans of creating a database of research and information on Indian political history," said Sinha.

Sahasrabuddhe, who is president of the Indian Council for Cultural Relations, took to Twitter to thank the prime minister and hit out at those opposing the proposed museum for all prime ministers.

"It's an honour to be on the board of Nehru Memorial Museum n Library! Many thanks PM @narendramodi ji, @dr_maheshsharma ji! Expectedly, those talking about Inclusive Democracy are opposing conversion of  NMML into all-PM Museum with Pt Nehru Memorial intact!", tweeted Sahasrabuddhe.

Ram Bahadur Rai is the chairman of the Indira Gandhi National Centre for the Arts

The 'bhoomi poojan' (foundation stone laying ceremony) for the museum was conducted by Culture Minister Mahesh Sharma on October 15 this year.

The NMML is also embroiled in a controversy over an eviction notice sent in September by the Directorate of Estates of the Union Ministry of Urban Development to the Jawaharlal Nehru Memorial Fund.

Established in 1964, the Fund has been located at Teen Murti, once the residence of India's first Prime Minister Jawaharlal Nehru, since 1967.

On November 1, however, the Delhi High Court stayed the eviction notice.

Comments

bangarappa
 - 
Sunday, 4 Nov 2018

loyal DOGS, SLAVES & bootlicker get promotion, true patroit get anti national award, what a day come to our belove country.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of the Oxford University developed Covid-19 vaccine candidate in the country.

Government officials said that the approval for conducting phase 2 and 3 clinical trials by the SII was granted by DCGI Dr V G Somani late Sunday night after a thorough evaluation based on the recommendations of the Subject Expert Committee (SEC) on Covid-19.

"The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials," a senior official said.

"As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on day 29) following which the safety and immunogenicity will be assessed at predefined intervals," the official said.

As a rapid regulatory response, the expert panel at the Central Drugs Standard Control Organisation (CDSCO) on Friday, after a detailed deliberation and considering the data generated on the vaccine candidate in phase 1 and 2 of the Oxford University trial, had recommended granting permission for phase 2 and 3 clinical trials of the potential vaccine, 'Covishield', on healthy adults in India,  the officials said.

Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

The officials said that the SII had submitted a revised proposal on Wednesday after the SEC on July 28, following deliberation over its application, had asked it to revise its protocol for the phase 2 and 3 clinical trials besides seeking some additional information.

The panel had also recommended that the clinical trial sites which have been proposed for the study be distributed across India.

According to the revised proposal by the SII, 1,600 people aged above 18 years will participate in the trials across 17 selected sites, including AIIMS-Delhi, B J Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Post Graduate Institute of Medical Education and Research in Chandigarh, AIIMS-Jodhpur, Nehru Hospital in Gorakhpur, Andhra Medical College in Visakhapatnam and JSS Academy of Higher Education and Research in Mysore.

"According to the application, it would conduct an observer-blind, randomised controlled study to determine the safety and immunogenicity of 'Covishield' on healthy Indian adults," the official said.

The SII, which has partnered with AstraZeneca, for manufacturing the Oxford vaccine candidate for Covid-19 had submitted its first application to the DCGI on July 25 seeking permission for conducting the phase 2 and 3 trials of the potential vaccine. 

Initial results of the first two-phases of trials of the vaccine conducted in five trial sites in the UK showed that it has an acceptable safety profile and homologous boosting increased antibody response, sources had said.

To introduce the vaccine, SII, the world's largest vaccine maker by number of doses produced and sold, has signed an agreement to manufacture the potential vaccine developed by the Jenner Institute (Oxford University) in collaboration with British-Swedish pharma company AstraZeneca. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
August 3,2020

New Delhi, Aug 3: President Ram Nath Kovind and Prime Minister Narendra Modi on Monday extended warm greetings and good wishes to the countrymen on the occasion of Rakshabandhan.

The President in his message said, "Greetings on Raksha Bandhan! Rakhi is the sacred thread of love and trust that connects sisters with brothers in a special bond. On this day, let us reiterate our commitment to secure the honour and dignity of women."

"Many wishes to all the countrymen on the auspicious occasion of Rakshabandhan," Prime Minister Modi tweeted in Hindi.

Rakshabandhan, which is being celebrated today, is a celebration of the unique bond between brothers and sisters. Tying of the Rakhi by sisters, symbolises love, affection and mutual trust between brothers and sisters. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 13,2020

New Delhi, May 13: Vice President M. Venkaiah Naidu on Wednesday said that Prime Minister Narendra Modi's announcement of Rs 20 lakh crore stimulus package "will go a long way in overcoming challenges" posed by the COVID-19 pandemic.

"Welcome the Rs. 20 lakh crore stimulus package announced by the Prime Minister, Shri Narendra Bhai Modi Ji to revive economy, boost efficiency of various sectors through reforms & make India self reliant and resilient. #AtmaNirbharBharatAbhiyan," the Vice President tweeted.

Calling the reforms as the "need of the hour", he further said: "Bold reforms are the need of the hour to realize the dream of #AtmanirbharBharat."

Expressing confidence in the five-pillar approach, he said that it would help promote local industries "while making India face global competition effectively".

"I am confident that a focused approach on the five pillars- Economy, Infrastructure, Technology driven System, Vibrant Demography & Demand--will promote local industries led growth while making India face global competition effectively. #AtmaNirbharBharatAbhiyan," he said.

"I am certain this timely economic package will go long way in overcoming challenges posed by the unprecedented COVID-19 pandemic. #AtmaNirbharBharatAbhiyan #IndiaFightsCorona," he wrote on the micro-blogging site.

The Prime Minister had on Tuesday announced Rs 20 lakh crore special economic package for the country to become 'self-reliant' and deal with COVID-19.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.